NCT01664130View on ClinicalTrials.gov

High-Dose Stereotactic Radiation for Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 12, 2017

Study Completion Date

January 12, 2017

Conditions
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate Cancer
Interventions
RADIATION

stereotactic body radiation therapy

Undergo SBRT

PROCEDURE

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT01664130 - High-Dose Stereotactic Radiation for Prostate Cancer | Biotech Hunter | Biotech Hunter